Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported second-quarter profit of $107.1 million.
The Silver Spring, Maryland-based company said it had net income of $2.41 per share.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for earnings of $2.41 per share.
The drugmaker posted revenue of $362 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $340.8 million.
Insight by Apptio: Download the results of his strategic guidance survey and learn how CIOs at ITA, LoC and other agencies are maximizing their investments to make sure resources are aligned to mission goals.
United Therapeutics shares have increased 28% since the beginning of the year. The stock has increased 45% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.